HBIO Harvard Bioscience, Inc.
$8.35▲ +0.36%
Healthcare
Other
Volume 6.0K
Avg Volume (10D) 15.8K
Key Metrics & Fundamentals
Market Cap
$38.01M
P/E Ratio
–
Div Yield
0.00%
52W Range
4.00 - 9.40
% vs 50 MA
3.96%
% vs 200 MA
30.57%
RSI-14
56.2
MACD Histogram
-0.0200
Beta (1Y vs SPY)
1.23
Free Cash Flow
-$591,000
Gross Rev
$22.73M
Gross Profit
$12.63M
EBITDA
$590,000
COGS
$10.10M
Operating Exp
$13.29M
Operating Income
-$660,000
EBIT
-$660,000
Pretax Income
-$2.90M
Net Income
-$2.91M
EPS (Diluted)
-0.64
Price & Volume History
Loading chart…
Recent News
Harvard Bioscience Schedules Third Quarter 2026 Earnings Conference Call for November 10, 2026 at 8:00 AM ET
GlobeNewswire · Oct 27, 2026 7:30 AM ET
Harvard Bioscience Announces Creation of Scientific Advisory Board
GlobeNewswire · Oct 6, 2026 4:05 PM ET
Harvard Bioscience (HBIO) Q2 2026 Earnings Call Transcript
Motley Fool · Aug 18, 2026 9:42 AM ET
Harvard Bioscience, Inc. Q2 2026 Earnings Call Summary
Moby · Aug 11, 2026 5:07 PM ET
Harvard Bioscience Inc (HBIO) (Q2 2026) Earnings Call Highlights: Revenue Surges 11% and ...
GuruFocus.com · Aug 11, 2026 3:01 PM ET
Harvard Bioscience beats Q2 estimates and raises 2026 revenue guidance
InvestorsHub · Aug 11, 2026 10:09 AM ET
Harvard Bioscience: Q2 Earnings Snapshot
Associated Press · Aug 11, 2026 7:13 AM ET
Harvard Bioscience Announces Second Quarter 2026 Financial Results
GlobeNewswire · Aug 11, 2026 7:00 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See HBIO's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.